4.7 Review

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension

Related references

Note: Only part of the references are listed.
Article Respiratory System

AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study

Hunter Gillies et al.

Summary: AV-101, a dry powder inhaled formulation of imatinib, was well tolerated in healthy adults and significantly reduced the systemic exposure of imatinib compared with oral imatinib. An ongoing study will evaluate the safety, tolerability, and clinical benefit of AV-101 for pulmonary arterial hypertension.

ERJ OPEN RESEARCH (2023)

Article Pharmacology & Pharmacy

Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?

Ayedh K. K. Alamri et al.

Summary: Pulmonary arterial hypertension (PAH) is a progressive disease with a 7-year survival rate of approximately 50%, despite advancements in therapy. Risk factors for developing PAH include methamphetamine use, scleroderma, human immunodeficiency virus, portal hypertension, and genetic predisposition. PAH is characterized by impaired vasodilation, enhanced vasoconstriction, and proliferation in the pulmonary vasculature, involving pathways such as nitric oxide, prostacyclin, thromboxane A2, and endothelin-1. This paper discusses novel drugs targeting new and alternative pathways for treating PAH, in addition to the traditional pathways targeted by established PAH medications.

DRUGS (2023)

Article Respiratory System

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert et al.

EUROPEAN RESPIRATORY JOURNAL (2023)

Review Immunology

Role of macrophages in pulmonary arterial hypertension

Meng-Qi Zhang et al.

Summary: Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease characterized by progressive elevation of pulmonary artery pressure and resistance, leading to right heart failure. Immune cells, particularly macrophages, play a crucial role in exacerbating pulmonary vascular remodeling in PAH by secreting chemokines and growth factors. Understanding the interactions between macrophages and other cells, as well as the factors influencing their polarization and functional changes, can provide insights for the development of immune-targeted therapies for PAH.

FRONTIERS IN IMMUNOLOGY (2023)

Review Respiratory System

New trends in pulmonary hypertension

Sarah Cullivan et al.

Summary: Pulmonary hypertension is a prevalent disease with high morbidity and mortality. Efforts have been made to improve disease recognition, diagnosis, and management, reflected in the updated guidelines. Changes in the definition, risk stratification, and emphasis on comorbidities and phenotyping provide new opportunities for early identification and patient-centered treatment decisions. New treatment pathways and potential targeted therapies are emerging, along with the recognition of the importance of supervised training and interventional therapies. This article highlights the trends in pulmonary hypertension, focusing on the revised guidelines.

EUROPEAN RESPIRATORY REVIEW (2023)

Article Biochemistry & Molecular Biology

Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells

Benjamin Le Vely et al.

Summary: This study found that cAbl concentrations were lower in the endothelium of remodeled pulmonary vessels in patients with PAH. In vitro and in vivo experiments showed that PAH-ECs had lower cAbl expression and activity, as well as altered DNA damage response and capacity of tube formation. Downregulation of cAbl resulted in genomic instability and the failure to form tubes, while upregulation of cAbl reduced DNA damage and apoptosis in PAH-ECs.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Multidisciplinary Sciences

The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans

Robert C. Jones et al.

Summary: The molecular characterization of cell types using single-cell transcriptome sequencing has led to a revolution in cell biology and provided new insights into the physiology of human organs. In this study, a human reference atlas was created, consisting of nearly 500,000 cells from 24 different tissues and organs, allowing for the molecular characterization of over 400 cell types, their tissue distribution, and tissue-specific variation in gene expression. By using multiple tissues from the same donor, the clonal distribution of T cells, tissue-specific mutation rate in B cells, and the analysis of cell cycle state and proliferative potential of shared cell types across tissues were identified. Additionally, cell type-specific RNA splicing was discovered and analyzed within an individual.

SCIENCE (2022)

Article Respiratory System

Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension

Anna Galkin et al.

Summary: This study evaluated the preclinical efficacy of a novel small-molecule kinase inhibitor, seralutinib, in treating pulmonary arterial hypertension (PAH) and compared it to a proof-of-concept kinase inhibitor, imatinib. The results showed that seralutinib demonstrated higher efficacy in two rat models of PAH, with positive effects on cardiopulmonary hemodynamic parameters, inflammation, and cell signaling.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Medicine, Research & Experimental

Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension

Aglaia Ntokou et al.

Summary: The study reveals that macrophage-derived PDGF-B plays a critical role in pulmonary hypertension, and inhibition of lung macrophage PDGF-B using nanoparticles holds significant implications as an interventional strategy.

JCI INSIGHT (2021)

Article Genetics & Heredity

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Na Zhu et al.

Summary: The study identified seven genes with rare deleterious variants associated with IPAH, including three known genes and two new candidate genes; analysis of pediatric IPAH showed a significant burden of de novo variants, with at least eight novel candidate genes related to lung/heart development.

GENOME MEDICINE (2021)

Article Critical Care Medicine

Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ

Christoph M. Zehendner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension

Didem Saygin et al.

PULMONARY CIRCULATION (2020)

Article Respiratory System

CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension

Shariq Abid et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Article Immunology

Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib

Nessrine Bellamri et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

Article Hematology

SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization

Koung Li Kim et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome

Robert S. Stearman et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Letter Critical Care Medicine

Nintedanib in Severe Pulmonary Arterial Hypertension

Manuel J. Richter et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Circuit Design Features of a Stable Two-Cell System

Xu Zhou et al.

Article Respiratory System

CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages

Lydia Meziani et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Article Respiratory System

Dasatinib increases endothelial permeability leading to pleural effusion

Carole Phan et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Review Biochemistry & Molecular Biology

Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?

Gareth R. Willis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

Macrophages in radiation injury: a new therapeutic target

Lydia Meziani et al.

ONCOIMMUNOLOGY (2018)

Article Medicine, Research & Experimental

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

Christophe Guignabert et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Hematology

Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension

Henrik ten Freyhaus et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

Article Cell Biology

Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension

Abdul Q. Sheikh et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Gastroenterology & Hepatology

PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors

Chunsheng Liu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension

Marlene Rabinovitch et al.

CIRCULATION RESEARCH (2014)

Article Medicine, Research & Experimental

Imatinib Activates Pathological Hypertrophy by Altering Myocyte Calcium Regulation

Larry A. Barr et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2014)

Article Multidisciplinary Sciences

BMP Pathway Regulation of and by Macrophages

Megha Talati et al.

PLOS ONE (2014)

Article Cell Biology

CSF-1 Receptor Signaling in Myeloid Cells

E. Richard Stanley et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Imatinib in pulmonary arterial hypertension: c-Kit inhibition

Samar Farha et al.

PULMONARY CIRCULATION (2014)

Article Multidisciplinary Sciences

Abl Family Kinases Regulate Endothelial Barrier Function In Vitro and in Mice

Elizabeth M. Chislock et al.

PLOS ONE (2013)

Article Critical Care Medicine

Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension

Rajkumar Savai et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Article Critical Care Medicine

Mast Cell Inhibition Improves Pulmonary Vascular Remodeling in Pulmonary Hypertension

Beatrijs Bartelds et al.

CHEST (2012)

Article Cardiac & Cardiovascular Systems

Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

David Montani et al.

CIRCULATION (2012)

Review Physiology

STEM CELL FACTOR RECEPTOR/c-KIT: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS

Johan Lennartsson et al.

PHYSIOLOGICAL REVIEWS (2012)

Article Critical Care Medicine

C-Kit-Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension

David Montani et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome Reversal by Macrophage Depletion

Thenappan Thenappan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells

Koung Li Kim et al.

CARDIOVASCULAR RESEARCH (2011)

Article Multidisciplinary Sciences

PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress

Ying-Xin Qi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Critical Care Medicine

Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension

Mark Toshner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Critical Care Medicine

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

Frederic Perros et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Hematology

Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury

Chao-Hung Wang et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Risto Kerkela et al.

NATURE MEDICINE (2006)

Article Medicine, Research & Experimental

Reversal of experimental pulmonary hypertension by PDGF inhibition

RT Schermuly et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)